Physiologic studies with saralasin in animals.
D000311:Adrenal Glands / Q000187:drug effects; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors; D057911:Angiotensin Receptor Antagonists; D000809:Angiotensins / Q000037:antagonists & inhibitors*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects / Q000378:metabolism; D004285:Dogs; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006973:Hypertension / Q000503:physiopathology; D009638:Norepinephrine / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D011945:Receptors, Angiotensin / Q000378:metabolism; D012083:Renin / Q000378:metabolism / Q000502:physiology; D012504:Saralasin / Q000494:pharmacology / Q000502:physiology*; D012964:Sodium / Q000378:metabolism; D000092502:Renin Inhibitors
D000804:Angiotensin II; D057911:Angiotensin Receptor Antagonists; D000809:Angiotensins; D009638:Norepinephrine; D011945:Receptors, Angiotensin; D012083:Renin; D012504:Saralasin; D012964:Sodium; D000092502:Renin Inhibitors